Oral nicotine pouch manufacturer's reduced exposure claims require evidence and regulatory oversight

Tob Control. 2025 May 15;34(3):410-411. doi: 10.1136/tc-2024-058610.

Mahmood A Alalwan^{1

2}, Darren Mays^{3

2}, Micah L Berman^{2

4

5}, Ahmad El-Hellani^{2

6}, Brittney L Keller-Hamilton^{3

2}, Marielle C Brinkman^{2

7}, Theodore L Wagener^{3

2}, Alayna P Tackett^{3

2}

¹ Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA alalwan.2@osu.edu.
² Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
³ Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
⁴ Division of Health Services Management and Policy, The Ohio State University College of Public Health, Columbus, Ohio, USA.
⁵ The Ohio State University Moritz College of Law, Columbus, Ohio, USA.
⁶ Division of Environmental Health Sciences, The Ohio State University, Columbus, Ohio, USA.
⁷ Division of Epidemiology, The Ohio State University College of Public Health, Columbus, Ohio, USA.

No abstract available

Keywords: Nicotine; Non-cigarette tobacco products; Tobacco industry.

Grants and funding